BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 32113654)

  • 1. The B7-H4 gene induces immune escape partly via upregulating the PD-1/Stat3 pathway in non-small cell lung cancer.
    Yuan L; Ye J; Fan D
    Hum Immunol; 2020 May; 81(5):254-261. PubMed ID: 32113654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor-1 receptor induces immunosuppression in lung cancer by upregulating B7-H4 expression through the MEK/ERK signaling pathway.
    Zhao Z; Zhang N; Li A; Zhou B; Chen Y; Chen S; Huang M; Wu F; Zhang L
    Cancer Lett; 2020 Aug; 485():14-26. PubMed ID: 32417396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B7-H4 facilitates proliferation of esophageal squamous cell carcinoma cells through promoting interleukin-6/signal transducer and activator of transcription 3 pathway activation.
    Chen X; Wang L; Wang W; Zhao L; Shan B
    Cancer Sci; 2016 Jul; 107(7):944-54. PubMed ID: 27088889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis.
    Tan Z; Shen W
    Oncotarget; 2017 Apr; 8(16):27137-27144. PubMed ID: 28404927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes.
    Altan M; Pelekanou V; Schalper KA; Toki M; Gaule P; Syrigos K; Herbst RS; Rimm DL
    Clin Cancer Res; 2017 Sep; 23(17):5202-5209. PubMed ID: 28539467
    [No Abstract]   [Full Text] [Related]  

  • 6. Induced expression of B7-H4 on the surface of lung cancer cell by the tumor-associated macrophages: a potential mechanism of immune escape.
    Chen C; Qu QX; Shen Y; Mu CY; Zhu YB; Zhang XG; Huang JA
    Cancer Lett; 2012 Apr; 317(1):99-105. PubMed ID: 22108530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced T cell immunity by B7-H4 downregulation in nonsmall-cell lung cancer cell lines.
    Sun SQ; Jiang CG; Lin Y; Jin YL; Huang PL
    J Int Med Res; 2012; 40(2):497-506. PubMed ID: 22613410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmed death-1 upregulation is correlated with dysfunction of tumor-infiltrating CD8+ T lymphocytes in human non-small cell lung cancer.
    Zhang Y; Huang S; Gong D; Qin Y; Shen Q
    Cell Mol Immunol; 2010 Sep; 7(5):389-95. PubMed ID: 20514052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer.
    Mao Y; Li W; Chen K; Xie Y; Liu Q; Yao M; Duan W; Zhou X; Liang R; Tao M
    Oncotarget; 2015 Feb; 6(5):3452-61. PubMed ID: 25609202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative roles of B7-H3 and B7-H4 in the microenvironment of cervical cancer.
    Han S; Wang Y; Shi X; Zong L; Liu L; Zhang J; Qian Q; Jin J; Ma Y; Cui B; Yang X; Kong B; Zhang Y
    Exp Cell Res; 2018 Oct; 371(1):222-230. PubMed ID: 30099052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7-H4(B7x)-Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients.
    Yao Y; Ye H; Qi Z; Mo L; Yue Q; Baral A; Hoon DSB; Vera JC; Heiss JD; Chen CC; Zhang J; Jin K; Wang Y; Zang X; Mao Y; Zhou L
    Clin Cancer Res; 2016 Jun; 22(11):2778-2790. PubMed ID: 27001312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC).
    Carvajal-Hausdorf D; Altan M; Velcheti V; Gettinger SN; Herbst RS; Rimm DL; Schalper KA
    J Immunother Cancer; 2019 Mar; 7(1):65. PubMed ID: 30850021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Converged Rab37/IL-6 trafficking and STAT3/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment.
    Kuo IY; Yang YE; Yang PS; Tsai YJ; Tzeng HT; Cheng HC; Kuo WT; Su WC; Chang CP; Wang YC
    Theranostics; 2021; 11(14):7029-7044. PubMed ID: 34093869
    [No Abstract]   [Full Text] [Related]  

  • 14. B7-H4 promotes tumor growth and metastatic progression in lung cancer by impacting cell proliferation and survival.
    Zhang X; Cai L; Zhang G; Shen Y; Huang J
    Oncotarget; 2017 Mar; 8(12):18861-18871. PubMed ID: 28061481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
    Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
    Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BIN1 reverses PD-L1-mediated immune escape by inactivating the c-MYC and EGFR/MAPK signaling pathways in non-small cell lung cancer.
    Wang J; Jia Y; Zhao S; Zhang X; Wang X; Han X; Wang Y; Ma M; Shi J; Liu L
    Oncogene; 2017 Nov; 36(45):6235-6243. PubMed ID: 28714960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer.
    Schalper KA; Carvajal-Hausdorf D; McLaughlin J; Altan M; Velcheti V; Gaule P; Sanmamed MF; Chen L; Herbst RS; Rimm DL
    Clin Cancer Res; 2017 Jan; 23(2):370-378. PubMed ID: 27440266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The superior efficacy of anti-PD-1/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity.
    Liu C; Zheng S; Jin R; Wang X; Wang F; Zang R; Xu H; Lu Z; Huang J; Lei Y; Mao S; Wang Y; Feng X; Sun N; Wang Y; He J
    Cancer Lett; 2020 Feb; 470():95-105. PubMed ID: 31644929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TPPP3 Promotes Cell Proliferation, Invasion and Tumor Metastasis via STAT3/ Twist1 Pathway in Non-Small-Cell Lung Carcinoma.
    Li Y; Bai M; Xu Y; Zhao W; Liu N; Yu J
    Cell Physiol Biochem; 2018; 50(5):2004-2016. PubMed ID: 30404076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B7-H4 expression promotes non-small cell lung cancer progression via AMPK/mTOR signaling.
    Li M; Che N; Feng Y; Liu X; Piao L; Xuan Y; Jin Y
    Exp Mol Pathol; 2022 Apr; 125():104755. PubMed ID: 35278461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.